APA (7th ed.) Citation

Narendran, N., Bailey, C., Downey, L., Gale, R., Kotagiri, A., Pearce, I., . . . Seeborne, T. (2024). Expert Panel Consensus for Optimizing Outcomes in Neovascular Age-Related Macular Degeneration in the Context of Suboptimal Response to a Biosimilar: The Role of Aflibercept. Clinical Ophthalmology, 18, 3133. https://doi.org/10.2147/OPTH.S481772

Chicago Style (17th ed.) Citation

Narendran, Nirodhini, et al. "Expert Panel Consensus for Optimizing Outcomes in Neovascular Age-Related Macular Degeneration in the Context of Suboptimal Response to a Biosimilar: The Role of Aflibercept." Clinical Ophthalmology 18 (2024): 3133. https://doi.org/10.2147/OPTH.S481772.

MLA (9th ed.) Citation

Narendran, Nirodhini, et al. "Expert Panel Consensus for Optimizing Outcomes in Neovascular Age-Related Macular Degeneration in the Context of Suboptimal Response to a Biosimilar: The Role of Aflibercept." Clinical Ophthalmology, vol. 18, 2024, p. 3133, https://doi.org/10.2147/OPTH.S481772.